2300 | Humans |
1936 | Parkinson Disease |
1328 | Male |
1273 | Female |
995 | Middle Aged |
993 | Aged |
700 | Animals |
462 | Adult |
319 | Levodopa |
311 | Brain |
300 | Antiparkinson Agents |
290 | Aged, 80 and over |
262 | Dopamine |
188 | Neurons |
171 | Rats |
167 | Case-Control Studies |
163 | Parkinson Disease, Secondary |
154 | Treatment Outcome |
152 | Disease Models, Animal |
150 | Mice |
145 | Corpus Striatum |
144 | Severity of Illness Index |
138 | Deep Brain Stimulation |
134 | Magnetic Resonance Imaging |
132 | Time Factors |
131 | Neuropsychological Tests |
129 | Substantia Nigra |
119 | Alzheimer Disease |
114 | Dyskinesia, Drug-Induced |
113 | Psychomotor Performance |
112 | Canada |
109 | Subthalamic Nucleus |
102 | Wolff-Parkinson-White Syndrome |
101 | Risk Factors |
101 | Follow-Up Studies |
100 | Cognition Disorders |
99 | Dementia |
98 | Motor Activity |
98 | Disease Progression |
97 | Tremor |
97 | Dopamine Agents |
97 | Analysis of Variance |
95 | Movement |
95 | Globus Pallidus |
82 | Mutation |
82 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
81 | Tomography, Emission-Computed |
80 | Retrospective Studies |
79 | alpha-Synuclein |
78 | Adolescent |
76 | Positron-Emission Tomography |
74 | Basal Ganglia |
73 | Brain Mapping |
72 | Dopamine Agonists |
72 | Cohort Studies |
70 | Dose-Response Relationship, Drug |
69 | Macaca fascicularis |
68 | Reproducibility of Results |
67 | Neural Pathways |
67 | Movement Disorders |
65 | Reaction Time |
65 | Quality of Life |
65 | Functional Laterality |
64 | Rats, Sprague-Dawley |
62 | Immunohistochemistry |
62 | Age Factors |
60 | Electrocardiography |
59 | Surveys and Questionnaires |
59 | Double-Blind Method |
57 | Neuroprotective Agents |
57 | Cerebral Cortex |
56 | Electromyography |
54 | Prevalence |
54 | Parkinsonian Disorders |
53 | Ubiquitin-Protein Ligases |
53 | Aging |
52 | Receptors, Dopamine |
52 | Motor Cortex |
52 | Mice, Inbred C57BL |
51 | Signal Transduction |
51 | REM Sleep Behavior Disorder |
51 | Cells, Cultured |
50 | Nerve Tissue Proteins |
50 | Dopamine Plasma Membrane Transport Proteins |
50 | Diagnosis, Differential |
50 | Behavior, Animal |
48 | Neurodegenerative Diseases |
48 | Molecular Sequence Data |
48 | Models, Biological |
48 | Electric Stimulation Therapy |
47 | Tyrosine 3-Monooxygenase |
47 | Reference Values |
47 | Prospective Studies |
47 | Oxidopamine |
46 | Neurologic Examination |
46 | Image Processing, Computer-Assisted |
46 | Heart Conduction System |
46 | Genetic Predisposition to Disease |
46 | Cognition |
45 | Gait Disorders, Neurologic |
45 | Clinical Trials as Topic |
45 | Biomechanical Phenomena |
44 | Oxidative Stress |
44 | Mitochondria |
44 | Gait |
44 | Child |
44 | Antipsychotic Agents |
43 | United States |
43 | Protein-Serine-Threonine Kinases |
43 | Activities of Daily Living |
42 | Receptors, Dopamine D2 |
42 | RNA, Messenger |
42 | Putamen |
42 | Nerve Degeneration |
42 | Dihydroxyphenylalanine |
42 | Amino Acid Sequence |
41 | MPTP Poisoning |
41 | Dopaminergic Neurons |
41 | Brain Chemistry |
40 | Protein Binding |
40 | Biomarkers |
40 | Action Potentials |
39 | Thalamus |
39 | Predictive Value of Tests |
39 | Postural Balance |
39 | Huntington Disease |
39 | Disability Evaluation |
39 | Cross-Sectional Studies |
38 | Young Adult |
38 | Depression |
38 | Amyotrophic Lateral Sclerosis |
37 | Sensitivity and Specificity |
37 | Longitudinal Studies |
37 | Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 |
37 | Cell Survival |
37 | Catheter Ablation |
37 | Algorithms |
36 | Stereotaxic Techniques |
36 | Psychiatric Status Rating Scales |
35 | Posture |
35 | Gene Expression Regulation |
35 | Electric Stimulation |
35 | Astrocytes |
34 | Mesencephalon |
34 | Lewy Bodies |
34 | Electrophysiology |
34 | Age of Onset |
33 | Mice, Knockout |
33 | Genotype |
33 | Drug Therapy, Combination |
32 | Phenotype |
32 | Electroencephalography |
32 | Electrodes, Implanted |
31 | Receptors, Dopamine D1 |
31 | Postoperative Complications |
31 | Neostriatum |
31 | Muscle, Skeletal |
31 | Carbidopa |
31 | Adenosine |
30 | Polysomnography |
30 | Memory |
30 | Lewy Body Disease |
30 | Attention |
29 | Sex Factors |
29 | Photic Stimulation |
29 | Microelectrodes |
29 | Mental Disorders |
29 | Dopamine Antagonists |
28 | tau Proteins |
28 | Supranuclear Palsy, Progressive |
28 | Protein Kinases |
28 | Mice, Transgenic |
28 | Hippocampus |
28 | Carrier Proteins |
27 | Statistics, Nonparametric |
27 | Randomized Controlled Trials as Topic |
27 | Ontario |
27 | Neurotoxins |
27 | Motor Skills |
27 | Models, Neurological |
27 | Fetal Tissue Transplantation |
27 | Dystonia |
27 | Cell Line |
27 | Caudate Nucleus |
26 | Pilot Projects |
26 | Nerve Net |
26 | Membrane Transport Proteins |
26 | Incidence |
26 | Fluorine Radioisotopes |
26 | Essential Tremor |
26 | Autoradiography |
25 | Tomography, Emission-Computed, Single-Photon |
25 | Schizophrenia |
25 | Phylogeny |
25 | Neurosurgical Procedures |
25 | Base Sequence |
25 | Apomorphine |
25 | Accidental Falls |
24 | Walking |
24 | Muscle Rigidity |
24 | Microglia |
24 | Membrane Proteins |
24 | Membrane Glycoproteins |
24 | Locomotion |
24 | Frontal Lobe |
23 | Sleep Wake Disorders |
23 | Prognosis |
23 | Polymorphism, Single Nucleotide |
23 | Evoked Potentials, Motor |
23 | Comorbidity |
23 | Cerebellum |
23 | Autophagy |
23 | Antioxidants |
22 | Selegiline |
22 | Pedigree |
22 | Neuroimaging |
22 | Inflammation |
22 | Hypokinesia |
22 | Dyskinesias |
22 | Cell Line, Tumor |
22 | Cell Death |
22 | Brain Tissue Transplantation |
22 | Blotting, Western |
22 | Binding Sites |
22 | Benzothiazoles |
22 | Anxiety |
21 | Risk Assessment |
21 | Environmental Exposure |
21 | Drug Combinations |
21 | British Columbia |
21 | Atrial Fibrillation |
20 | Tritium |
20 | Synaptic Transmission |
20 | Synapses |
20 | Regression Analysis |
20 | Neuronal Plasticity |
20 | Nervous System Diseases |
20 | Multiple Sclerosis |
20 | History, 20th Century |
20 | Disruptive, Impulse Control, and Conduct Disorders |
20 | Depressive Disorder |
20 | Data Interpretation, Statistical |
20 | Cerebrovascular Circulation |
20 | Cell Count |
20 | Cardiac Pacing, Artificial |
20 | Apoptosis |
19 | Transcranial Magnetic Stimulation |
19 | Statistics as Topic |
19 | Reactive Oxygen Species |
19 | Raclopride |
19 | Psychotic Disorders |
19 | Placebo Effect |
19 | Monoamine Oxidase Inhibitors |
19 | Genetic Therapy |
19 | Gene Expression |
19 | Databases, Factual |
19 | DNA Mutational Analysis |
19 | Carbon Radioisotopes |
19 | Biological Transport |
18 | Serotonin |
18 | Reverse Transcriptase Polymerase Chain Reaction |
18 | Radiopharmaceuticals |
18 | Radioligand Assay |
18 | Protein Structure, Tertiary |
18 | Outcome Assessment (Health Care) |
18 | Multiple System Atrophy |
18 | Learning |
18 | Iron |
18 | Image Interpretation, Computer-Assisted |
18 | HEK293 Cells |
18 | Gambling |
18 | Binding, Competitive |
18 | Autonomic Nervous System Diseases |
17 | Transcription Factors |
17 | Thiazoles |
17 | Task Performance and Analysis |
17 | Signal Processing, Computer-Assisted |
17 | Proportional Hazards Models |
17 | Phosphorylation |
17 | Pedunculopontine Tegmental Nucleus |
17 | Pain |
17 | Indoles |
17 | In Vitro Techniques |
17 | Executive Function |
17 | Enzyme Inhibitors |
17 | Drosophila melanogaster |
17 | Drosophila Proteins |
17 | Cues |
17 | Computer Simulation |
17 | Caregivers |
17 | Adaptation, Physiological |
16 | Up-Regulation |
16 | Tomography, X-Ray Computed |
16 | Thioinosine |
16 | Syndrome |
16 | Risk |
16 | Rats, Long-Evans |
16 | Quebec |
16 | Prefrontal Cortex |
16 | Models, Statistical |
16 | Mental Status Schedule |
16 | Logistic Models |
16 | Kinetics |
16 | Glucose |
16 | Genomics |
16 | Genome-Wide Association Study |
16 | Drug Administration Schedule |
16 | Computational Biology |
16 | Cognitive Dysfunction |
16 | Bromocriptine |
16 | Blood-Brain Barrier |
16 | Autopsy |
15 | Ubiquitination |
15 | Tetrabenazine |
15 | Rats, Wistar |
15 | Protein Deglycase DJ-1 |
15 | Pregnancy |
15 | Oncogene Proteins |
15 | Mood Disorders |
15 | Memory Disorders |
15 | Intracellular Signaling Peptides and Proteins |
15 | Infant |
15 | In Situ Hybridization |
15 | Homovanillic Acid |
15 | Guam |
15 | Gene Frequency |
15 | Excitatory Amino Acid Antagonists |
15 | Child, Preschool |
14 | Visual Perception |
14 | Tachycardia, Supraventricular |
14 | Protein Transport |
14 | Patient Selection |
14 | Neuroglia |
14 | Neurofibrillary Tangles |
14 | Hallucinations |
14 | Evoked Potentials |
14 | Ergolines |
14 | Enzyme Activation |
14 | Conserved Sequence |
14 | Atrioventricular Node |
14 | Amyloid beta-Peptides |
13 | Ubiquitin |
13 | Temporal Lobe |
13 | Software |
13 | Reward |
13 | Research Design |
13 | Radionuclide Imaging |
13 | Pyridines |
13 | Proteins |
13 | Protein Conformation |
13 | Ovariectomy |
13 | Organ Specificity |
13 | Occupational Exposure |
13 | Mental Recall |
13 | Genetic Testing |
13 | Gene Expression Profiling |
13 | Exons |
13 | Drug Interactions |
13 | Alberta |
13 | 3,4-Dihydroxyphenylacetic Acid |
12 | Tumor Cells, Cultured |
12 | Tachycardia, Atrioventricular Nodal Reentry |
12 | Stroke |
12 | Saskatchewan |
12 | Rotation |
12 | Restless Legs Syndrome |
12 | Psychoses, Substance-Induced |
12 | Piperidines |
12 | Olfaction Disorders |
12 | Neurotransmitter Agents |
12 | Neural Inhibition |
12 | Mutation, Missense |
12 | Models, Molecular |
12 | Genetic Association Studies |
12 | Fingers |
12 | Feedback, Sensory |
12 | Exercise Therapy |
12 | Evolution, Molecular |
12 | Enzyme-Linked Immunosorbent Assay |
12 | Environment |
12 | DNA-Binding Proteins |
12 | Cytokines |
12 | Cocaine |
12 | Chromatography, High Pressure Liquid |
12 | Atrophy |
12 | Arctic Regions |
12 | Animals, Genetically Modified |
11 | Tissue Distribution |
11 | Superoxide Dismutase |
11 | Rural Population |
11 | Receptors, N-Methyl-D-Aspartate |
11 | Random Allocation |
11 | Protein Processing, Post-Translational |
11 | Presynaptic Terminals |
11 | Pesticides |
11 | Oxygen |
11 | Norepinephrine |
11 | Neurology |
11 | Myocardium |
11 | Motor Neurons |
11 | Iodine Radioisotopes |
11 | Infant, Newborn |
11 | Imaging, Three-Dimensional |
11 | Haplotypes |
11 | Emotions |
11 | Catechols |
11 | Benzazepines |
11 | Amphetamine |
11 | Adenosine Triphosphate |
10 | User-Computer Interface |
10 | Transfection |
10 | Thalamic Nuclei |
10 | Synucleins |
10 | Survival Analysis |
10 | Species Specificity |
10 | Sleep |
10 | Sequence Analysis, DNA |
10 | Sequence Alignment |
10 | Sensation Disorders |
10 | Recovery of Function |
10 | Receptors, Dopamine D3 |
10 | Purines |
10 | Polymorphism, Genetic |
10 | Placebos |
10 | Peptide Fragments |
10 | Neurosurgery |
10 | Neuroblastoma |
10 | Neoplasms |
10 | Muscles |
10 | Mitochondrial Proteins |
10 | Magnetic Resonance Spectroscopy |
10 | International Cooperation |
10 | Inclusion Bodies |
10 | Heterozygote |
10 | Heme Oxygenase-1 |
10 | Health Care Costs |
10 | Haplorhini |
10 | Hand |
10 | Glutamic Acid |
10 | Genetic Vectors |
10 | Family |
10 | Family Health |
10 | Drug Resistance |
10 | Disease Management |
10 | Cluster Analysis |
10 | Central Nervous System Stimulants |
10 | Cell Transplantation |
10 | Cell Membrane |
10 | Catechol O-Methyltransferase |
10 | Catechol O-Methyltransferase Inhibitors |
10 | Calcium |
10 | Benzophenones |
10 | Arm |
10 | Antidepressive Agents |
10 | Affect |
10 | Adrenal Medulla |
10 | Adaptation, Psychological |
9 | Vesicular Monoamine Transport Proteins |
9 | Speech Perception |
9 | Speech Intelligibility |
9 | Space Perception |
9 | Social Support |
9 | Saccades |
9 | Rotenone |
9 | Recurrence |
9 | Receptor, Adenosine A2A |
9 | Proteasome Endopeptidase Complex |
9 | Proprioception |
9 | Physical Stimulation |
9 | Paraquat |
9 | PC12 Cells |
9 | Odds Ratio |
9 | Nitriles |
9 | Muscle Contraction |
9 | Motor Neuron Disease |
9 | Molecular Chaperones |
9 | Microinjections |
9 | Membrane Potentials |
9 | Indans |
9 | Haloperidol |
9 | Glucosylceramidase |
9 | Glial Cell Line-Derived Neurotrophic Factor |
9 | Genetic Variation |
9 | Genetic Linkage |
9 | Gene Expression Regulation, Enzymologic |
9 | Forelimb |
9 | Fluorodeoxyglucose F18 |
9 | Fetus |
9 | Energy Metabolism |
9 | Echocardiography |
9 | Early Diagnosis |
9 | Dominance, Cerebral |
9 | Cross-Over Studies |
9 | Combined Modality Therapy |
9 | Clozapine |
9 | Chronic Disease |
9 | Cholinergic Antagonists |
9 | Cattle |
9 | Brain Ischemia |
9 | Brain Diseases |